Safety, Tolerability and Pharmacokinetic Study of KL1333 in Healthy Male Volunteers

Clinical trial NCT03056209 · COMPLETED

Trial details

NCT number: NCT03056209
Sponsor: Yungjin Pharm. Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

MELAS Syndrome Mitochondrial Respiratory Chain Deficiencies

Start date: 2017-06-26
Primary completion: 2018-04-16
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.